Covalently attached intercalators restore duplex stability and splice-switching activity to triazole-modified oligonucleotides
Oligonucleotides are rapidly emerging as powerful therapeutics for hard to treat diseases. Short single-stranded oligonucleotides can base pair with target RNA and alter gene expression, providing an attractive therapeutic approach at the genetic level. Whilst conceptually appealing, oligonucleotide...
Auteurs principaux: | Dysko, A, Baker, YR, McClorey, G, Wood, MJA, Fenner, S, Williams, G, El-Sagheer, A, Brown, T |
---|---|
Format: | Journal article |
Langue: | English |
Publié: |
Royal Society of Chemistry
2022
|
Documents similaires
-
Design and application of bispecific splice-switching oligonucleotides.
par: Bestas, B, et autres
Publié: (2014) -
Cell-penetrating peptides to enhance delivery of Oligonucleotide-based therapeutics
par: McClorey, G, et autres
Publié: (2018) -
Splice-switching therapy for spinal muscular atrophy.
par: Meijboom, K, et autres
Publié: (2017) -
Immortalized canine dystrophic myoblast cell lines for development of peptide-conjugated splice-switching oligonucleotides
par: Tone, Y, et autres
Publié: (2021) -
Synthesis and properties of oligonucleotides containing triazole backbone linkages and 2′-modifications for therapeutic applications
par: Dysko, A
Publié: (2016)